,Type,Expense in million U.S. dollars
0,Stock-based compensation,48.26
1,Shared discovery and development expenses,59.1
2,Technical development and unallocated manufacturing expenses,85.3
3,Platform research,91.1
4,Discovery programs,55.38
5,Systemic intracellular therapeutics*,33.36
6,Systemic secreted and cell surface therapeutics*,11.24
7,Localized regenerative therapeutics*,33.26
8,Intratumoral immuno-oncology*,17.61
9,Cancer vaccines*,44.0
10,Prophylactic vaccines*,47.65
